| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1963 | 2020 |
| Towards large-scale twitter mining for drug-related adverse events J Bian, U Topaloglu, F Yu Proceedings of the 2012 international workshop on Smart health and wellbeing …, 2012 | 349 | 2012 |
| Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US J Sun, Q Zheng, V Madhira, AL Olex, AJ Anzalone, A Vinson, JA Singh, ... JAMA internal medicine 182 (2), 153-162, 2022 | 275 | 2022 |
| Using a federated network of real-world data to optimize clinical trials operations U Topaloglu, MB Palchuk JCO clinical cancer informatics 2, 1-10, 2018 | 249 | 2018 |
| Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label … A Alistar, BB Morris, R Desnoyer, HD Klepin, K Hosseinzadeh, C Clark, ... The lancet oncology 18 (6), 770-778, 2017 | 214 | 2017 |
| Characterizing long COVID: deep phenotype of a complex condition RR Deer, MA Rock, N Vasilevsky, L Carmody, H Rando, AJ Anzalone, ... EBioMedicine 74, 2021 | 201 | 2021 |
| Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported information HM Rando, TD Bennett, JB Byrd, C Bramante, TJ Callahan, CG Chute, ... MedRxiv, 2021 | 163 | 2021 |
| Dissecting intratumoral myeloid cell plasticity by single cell RNA‐seq Q Song, GA Hawkins, L Wudel, PC Chou, E Forbes, AK Pullikuth, L Liu, ... Cancer medicine 8 (6), 3072-3085, 2019 | 142 | 2019 |
| Outcomes of COVID-19 in patients with cancer: report from the National COVID Cohort Collaborative (N3C) N Sharafeldin, B Bates, Q Song, V Madhira, Y Yan, S Dong, E Lee, ... Journal of Clinical Oncology 39 (20), 2232-2246, 2021 | 136 | 2021 |
| Risk and outcome of breakthrough COVID-19 infections in vaccinated patients with cancer: real-world evidence from the national COVID cohort collaborative Q Song, B Bates, YR Shao, FC Hsu, F Liu, V Madhira, AK Mitra, ... Journal of Clinical Oncology 40 (13), 1414-1427, 2022 | 109 | 2022 |
| Incorporating blood-based liquid biopsy information into cancer staging: time for a TNMB system? M Yang, ME Forbes, RL Bitting, SS O'Neill, PC Chou, U Topaloglu, ... Annals of Oncology 29 (2), 311-323, 2018 | 105 | 2018 |
| Social network analysis of biomedical research collaboration networks in a CTSA institution J Bian, M Xie, U Topaloglu, T Hudson, H Eswaran, W Hogan Journal of biomedical informatics 52, 130-140, 2014 | 80 | 2014 |
| Exosomal miR-4466 from nicotine-activated neutrophils promotes tumor cell stemness and metabolism in lung cancer metastasis A Tyagi, SY Wu, S Sharma, K Wu, D Zhao, R Deshpande, R Singh, W Li, ... Oncogene 41 (22), 3079-3092, 2022 | 63 | 2022 |
| Cloud-based federated learning implementation across medical centers S Rajendran, JS Obeid, H Binol, R DAgostino Jr, K Foley, W Zhang, ... JCO clinical cancer informatics 5, 1-11, 2021 | 63 | 2021 |
| Racial disparities in COVID-19 outcomes among black and white patients with cancer J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ... JAMA network open 5 (3), e224304-e224304, 2022 | 58 | 2022 |
| Severe neurologic complications of immune checkpoint inhibitors: a single-center review S Mancone, T Lycan, T Ahmed, U Topaloglu, A Dothard, WJ Petty, ... Journal of neurology 265, 1636-1642, 2018 | 58 | 2018 |
| Association between androgen deprivation therapy and mortality among patients with prostate cancer and COVID-19 AL Schmidt, MD Tucker, Z Bakouny, C Labaki, CY Hsu, Y Shyr, ... JAMA network open 4 (11), e2134330-e2134330, 2021 | 43 | 2021 |
| SMARCA4 mutations in KRAS‐mutant lung adenocarcinoma: a multi‐cohort analysis L Liu, T Ahmed, WJ Petty, S Grant, J Ruiz, TW Lycan, U Topaloglu, ... Molecular oncology 15 (2), 462-472, 2020 | 42 | 2020 |
| Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19 Z Bakouny, C Labaki, P Grover, J Awosika, S Gulati, CY Hsu, ... JAMA oncology 9 (1), 128-134, 2023 | 41 | 2023 |
| Natural language processing and recurrent network models for identifying genomic mutation-associated cancer treatment change from patient progress notes M Guan, S Cho, R Petro, W Zhang, B Pasche, U Topaloglu JAMIA open 2 (1), 139-149, 2019 | 41 | 2019 |
Jiang BianRegenstrief Institue; Indiana University; IU Healthبريد إلكتروني تم التحقق منه على regenstrief.org